Abel Laurie, Zeroski Debra, Brammer Sarah, Butler Wayne, Wallner Kent E, Merrick Gregory S
Schiffler Cancer Center, Wheeling, WV, USA.
Urol Nurs. 2007 Dec;27(6):507-10, 518; quiz 511.
A common concern for patients who have undergone treatment for prostate cancer and their families is an elevation or spike in the PSA level following definitive treatment. A number of factors can be responsible for this, but often the PSA spike may be benign. An informed health care worker can reasonably assess whether this is the case, and can help to alleviate the fears of the patient and his family.
